Numinus Wellness Inc
Change company Symbol lookup
Select an option...
NUMIF Numinus Wellness Inc
RNWWW ReNew Energy Global Equity Warrant Exp 23rd Aug 2026 *W EXP 08/23/2026
RVPH Reviva Pharmaceuticals Holdings, Inc.
TPR Tapestry Inc
BGRY Berkshire Grey Inc
BKNG Booking Holdings Inc
UHT Universal Health Realty Income Trust
BBVA Banco Bilbao Vizcaya Argentaria SA
RILY B Riley Financial Inc

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Numinus Wellness Inc. is a Canada-based mental health care company. The Company develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research and development processes. The Company operates through three segments: Research Operations, the Canadian Clinic Network, and the U.S. Clinic Network. Its Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. The Canadian clinic network consists of Numinus Health Corp., Mindspace, and the NCT. It offers services, such as ketamine-assisted psychotherapy (KAP) for depression, neurological care and psychotherapy and counseling by registered psychologists. The U.S. Clinic Network consists of Cedar Psychiatry and Foundations for Change. It offers services, such as KAP for depression and psychotherapy and counseling by registered psychologists in the United States.

Closing Price
Day's Change
0.0038 (1.89%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:
Latest Earnings Met Consensus (Q1 ending 11/2022)Next Earnings Announcement
Announced January 16, 2023
-$0.02Q1 Estimate range
of 1 analyst
-$0.02 to -$0.02Q2 Earnings
will announce
(Unconfirmed) April 12, 2023

Quarterly Earnings History and Estimates

Show high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.



NUMIF's fiscal year ends in August

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.